Cargando…
Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia
OBJECTIVES: Alzheimer’s disease (AD) and behavioral variant frontotemporal dementia (bvFTD) are among the leading causes of early-onset dementia. This study aimed to assess the rate of whole brain atrophy by comparing bvFTD and AD. METHODS: Two patients (one man with AD, and one woman with bvFTD) ha...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833431/ https://www.ncbi.nlm.nih.gov/pubmed/31524019 http://dx.doi.org/10.1177/0300060519830830 |
_version_ | 1783466385242849280 |
---|---|
author | Marino, Silvia Bonanno, Lilla Lo Buono, Viviana Ciurleo, Rosella Corallo, Francesco Morabito, Rosa Chirico, Gaetano Marra, Angela Bramanti, Placido |
author_facet | Marino, Silvia Bonanno, Lilla Lo Buono, Viviana Ciurleo, Rosella Corallo, Francesco Morabito, Rosa Chirico, Gaetano Marra, Angela Bramanti, Placido |
author_sort | Marino, Silvia |
collection | PubMed |
description | OBJECTIVES: Alzheimer’s disease (AD) and behavioral variant frontotemporal dementia (bvFTD) are among the leading causes of early-onset dementia. This study aimed to assess the rate of whole brain atrophy by comparing bvFTD and AD. METHODS: Two patients (one man with AD, and one woman with bvFTD) had neuropsychological and neuroimaging assessment by using automated techniques for cross-sectional and longitudinal atrophy measurements. RESULTS: In the patient with AD, magnetic resonance imaging (MRI) showed decreased bilateral hippocampal and mesial-temporal volume. However, conventional images showed no difference between baseline (T0) and after 1 year (T1). In the patient with bvFTD, MRI showed bilateral frontotemporal lobe atrophy and a moderate increase in atrophy between T0 and T1, particularly in the temporal lobes. A cross-sectional cerebral volume examination showed a considerable reduction in brain volume in the patient with bvFDT and a moderate reduction in the patient with AD. A longitudinal cerebral volume examination showed a lower percentage brain volume change in the patient with bvFTS compared with the patient with AD. CONCLUSIONS: Our results suggest that bvFTD has more neurodegenerative progression. MRI findings should be considered as a reliable marker of disease progression in the brain. Our findings offer potential for monitoring treatment outcomes. |
format | Online Article Text |
id | pubmed-6833431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-68334312019-11-13 Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia Marino, Silvia Bonanno, Lilla Lo Buono, Viviana Ciurleo, Rosella Corallo, Francesco Morabito, Rosa Chirico, Gaetano Marra, Angela Bramanti, Placido J Int Med Res Clinical Research Reports OBJECTIVES: Alzheimer’s disease (AD) and behavioral variant frontotemporal dementia (bvFTD) are among the leading causes of early-onset dementia. This study aimed to assess the rate of whole brain atrophy by comparing bvFTD and AD. METHODS: Two patients (one man with AD, and one woman with bvFTD) had neuropsychological and neuroimaging assessment by using automated techniques for cross-sectional and longitudinal atrophy measurements. RESULTS: In the patient with AD, magnetic resonance imaging (MRI) showed decreased bilateral hippocampal and mesial-temporal volume. However, conventional images showed no difference between baseline (T0) and after 1 year (T1). In the patient with bvFTD, MRI showed bilateral frontotemporal lobe atrophy and a moderate increase in atrophy between T0 and T1, particularly in the temporal lobes. A cross-sectional cerebral volume examination showed a considerable reduction in brain volume in the patient with bvFDT and a moderate reduction in the patient with AD. A longitudinal cerebral volume examination showed a lower percentage brain volume change in the patient with bvFTS compared with the patient with AD. CONCLUSIONS: Our results suggest that bvFTD has more neurodegenerative progression. MRI findings should be considered as a reliable marker of disease progression in the brain. Our findings offer potential for monitoring treatment outcomes. SAGE Publications 2019-09-16 2019-10 /pmc/articles/PMC6833431/ /pubmed/31524019 http://dx.doi.org/10.1177/0300060519830830 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Clinical Research Reports Marino, Silvia Bonanno, Lilla Lo Buono, Viviana Ciurleo, Rosella Corallo, Francesco Morabito, Rosa Chirico, Gaetano Marra, Angela Bramanti, Placido Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia |
title | Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia |
title_full | Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia |
title_fullStr | Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia |
title_full_unstemmed | Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia |
title_short | Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia |
title_sort | longitudinal analysis of brain atrophy in alzheimer’s disease and frontotemporal dementia |
topic | Clinical Research Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833431/ https://www.ncbi.nlm.nih.gov/pubmed/31524019 http://dx.doi.org/10.1177/0300060519830830 |
work_keys_str_mv | AT marinosilvia longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia AT bonannolilla longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia AT lobuonoviviana longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia AT ciurleorosella longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia AT corallofrancesco longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia AT morabitorosa longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia AT chiricogaetano longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia AT marraangela longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia AT bramantiplacido longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia |